Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of an ACYW135 meningococcal conjugate vaccine in infants aged 6 to 11 months
CTR20260762Phase 3Active
- Sponsor
- Sino Biopharmaceutical Limited
- Start
- Mar 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal disease, sponsored by Sino Biopharmaceutical Limited. Started Mar 2026; status: active.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20260762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260762.